Literature DB >> 26949240

Clinical evaluation of specific oral and salivary findings of coeliac disease in eastern Turkish paediatric patients.

A Dane1, T Gürbüz2.   

Abstract

AIM: The aim of this study was to evaluate enamel defects (EDs), recurrent aphthous stomatitis (RAS) and salivary findings in Eastern Turkish children with coeliac disease (CD), and to compare the results with healthy children. STUDY
DESIGN: 70 children (35 CD patients and 35 healthy patients) aged between 5 to 15 years were included in this study. Intraoral examination was performed; saliva specimens were collected for analysis. Oral health conditions, tooth brushing frequency, saliva pH level, flow rate and buffering capacity were recorded. Kruskal-Wallis test was used for comparison of DMFT and dft index. Chi-squared test was used for the data of oral health status. The significance level was set at p = 0.05.
RESULTS: EDs were seen in 54.3% (19 patients) of the CD patients and more frequently than the controls (p < 0.05). Regarding RAS, 31.4% (11 patients) of the CD patients and none of control group had aphthous ulcers (p < 0.05). Salivary flow rate and buffering capacity were lower in CD patients (p < 0.05).
CONCLUSION: The oral examination could be a significant contribution to the detection of CD. Especially paediatric dentists can play an important role in the early diagnosis and may help paediatricians about CD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26949240

Source DB:  PubMed          Journal:  Eur J Paediatr Dent        ISSN: 1591-996X            Impact factor:   2.231


  2 in total

Review 1.  Saliva diagnostics - Current views and directions.

Authors:  Karolina Elżbieta Kaczor-Urbanowicz; Carmen Martin Carreras-Presas; Katri Aro; Michael Tu; Franklin Garcia-Godoy; David Tw Wong
Journal:  Exp Biol Med (Maywood)       Date:  2016-12-08

2.  Salivary gland involvement and oral health in patients with coeliac disease.

Authors:  Jason Liu; Ann-Kristine Juncker Lundemann; Jesper Reibel; Anne Marie Lynge Pedersen
Journal:  Eur J Oral Sci       Date:  2022-03-05       Impact factor: 2.160

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.